Publikationen, an denen er mitarbeitet E. Espinosa Arranz (2)

2023

  1. Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer

    Journal of Oncology Pharmacy Practice, Vol. 29, Núm. 7, pp. 1793-1796

2021

  1. Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 5, pp. 268-272